MoneyWorks4Me

Syschem (India) - Quaterly Results

05 Aug 2026 Evaluate
A slight decline in the revenue of Rs. 1259.48 millions was seen for the June 2026 quarter as against Rs. 1267.58 millions during year-ago period.The Net Loss for the quarter ended June 2026 is Rs. -16.68 millions as compared to Net Profit of Rs. 16.74 millions of corresponding quarter ended June 2025Operating profit for the quarter ended June 2026 decreased to 5.93 millions as compared to 24.70 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1259.48 1267.58 -0.64 1259.48 1267.58 -0.64 6546.26 3862.31 69.49
Other Income 0.47 0.05 840.00 0.47 0.05 840.00 0.21 0.42 -50.00
PBIDT 5.93 24.70 -75.99 5.93 24.70 -75.99 211.13 40.24 424.68
Interest 4.90 0.39 1156.41 4.90 0.39 1156.41 22.64 0.66 3330.30
PBDT 1.03 24.31 -95.76 1.03 24.31 -95.76 188.49 39.58 376.23
Depreciation 15.55 7.57 105.42 15.55 7.57 105.42 40.63 29.47 37.87
PBT -14.52 16.74 -186.74 -14.52 16.74 -186.74 147.86 10.11 1362.51
TAX 2.16 0.00 0.00 2.16 0.00 0.00 38.58 5.52 598.91
Deferred Tax 2.16 0.00 0.00 2.16 0.00 0.00 38.58 5.52 598.91
PAT -16.68 16.74 -199.64 -16.68 16.74 -199.64 109.28 4.59 2280.83
Equity 536.16 435.13 23.22 536.16 435.13 23.22 490.13 435.13 12.64
PBIDTM(%) 0.47 1.95 -75.84 0.47 1.95 -75.84 3.23 1.04 209.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..